98%
921
2 minutes
20
Sigma-1 receptor (S1R) is a Ca sensitive, ligand-operated receptor chaperone protein present on the endoplasmic reticulum (ER) membrane and more specifically at the mitochondria-associated ER membrane (MAM). Upon activation by ER calcium depletion or ligand binding, S1R can increase calcium efflux from the ER into the mitochondria by chaperoning IP3 receptor type3 (Ip3R3). Mitochondrial metabolism has an intricate relationship with glycolysis. Despite S1R affecting mitochondria, the relevance of S1R to glycolysis and its impact on the overall cellular energy metabolism is not known. This study utilizes wild-type (Wt) and S1R knockout (S1R KO) Neuro2a (N2a) cells and Wt and S1R KO mice for primary culture of cortical neurons studies and longitudinal imaging. In this manuscript we describe the fundamental functions of S1R on glycolysis, mitochondrial activity and NAD/NADH metabolism, keystone coenzymes essential for glycolysis and for mitochondrial activity. Both N2a cells and cortical neurons lacking S1R had reduced glycolytic activity, and increased mitochondria complex I protein GRIM19 but no change in mitochondrial oxygen consumption. Furthermore, we observed an increased NAD/NADH ratio in S1R KO condition. Positron emission tomography revealed decreased [F]fluorodeoxyglucose brain uptake in S1R KO mice. We observed that knocking down GRIM19 in S1R KO condition rescued the glycolysis deficit. Altogether, these data show for the first time that S1R modulates glycolysis and NAD metabolism in various neuronal systems. This new insight on the S1R function may lead to new therapeutic applications of S1R ligands where compromised glycolysis and cellular NAD+/NADH ratios occur such as aging and neurodegeneration.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324332 | PMC |
http://dx.doi.org/10.1101/2025.07.28.667250 | DOI Listing |
J Chem Inf Model
September 2025
Department of Chemical, Biological, Pharmaceutical and Environmental Sciences (CHIBIOFARAM), University of Messina, Viale Ferdinando D'Alcontres 13, I-98166 Messina, Italy.
Sigma (σ) receptors (SRs) have emerged as important therapeutic targets due to their roles in various biological pathways. They are classified into two subtypes: S1R, primarily distributed in the central nervous system and related to neuroprotection and neurodegenerative diseases, and S2R mainly expressed in cancer cells and associated with cell proliferation and apoptosis, as well as in neurons. Although S1R and S2R exhibit structural differences in receptor architecture and assembly, they share similar binding site features and ligand recognition mechanisms.
View Article and Find Full Text PDFEur J Pharmacol
August 2025
Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China. Electronic address:
Sigma 1 receptor (S1R), a ligand-regulated chaperone mainly located in the mitochondrion-associated endoplasmic reticulum membrane (MAM), has emerged as a potential target for chronic pain and depression. Over the past decades, numerous studies on chronic pain and depression have been conducted, aiming to find more effective therapies. However, the complex pathophysiological processes of these conditions limit the effectiveness of many clinical treatments.
View Article and Find Full Text PDFbioRxiv
July 2025
Cellular Pathobiology Section, Integrative Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, NIH/DHHS, Suite 3512, 333 Cassell Drive, Baltimore, MD, 21224, USA.
Sigma-1 receptor (S1R) is a Ca sensitive, ligand-operated receptor chaperone protein present on the endoplasmic reticulum (ER) membrane and more specifically at the mitochondria-associated ER membrane (MAM). Upon activation by ER calcium depletion or ligand binding, S1R can increase calcium efflux from the ER into the mitochondria by chaperoning IP3 receptor type3 (Ip3R3). Mitochondrial metabolism has an intricate relationship with glycolysis.
View Article and Find Full Text PDFBrain Res Bull
July 2025
Department of Anaesthesiology, Zhongnan Hospital, Wuhan University, Wuhan, China. Electronic address:
Background: The comorbidity of chronic pain and anxiety exerts a profound impact on neurological functions. This study aims to investigate the alterations in brain metabolism and functional connectivity that arise from the interaction between chronic pain and anxiety in rats. Furthermore, the potential therapeutic effects of esketamine on these alterations are examined.
View Article and Find Full Text PDFCells
July 2025
Department of Molecular Medicine, Human Physiology Unit, University of Pavia, 27100 Pavia, Italy.
Sigma1 receptor (S1R) and some aquaporins (AQPs) are involved in controlling oxidative stress, but only recently has their possible interaction emerged. S1R acts by interacting with proteins in the plasma membrane and organelles and AQPs by favoring the hydrogen peroxide (HO) cell removal. To date, the possible regulation of peroxiporins by S1R has not been explored.
View Article and Find Full Text PDF